MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7554/elife.103904

Медицинская библиотека · eLife · 2025

NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer.

Zhao Shengsheng, Lin Ji, Zhu Bingzi, Jin Yin, Dong Qiantong, Ruan Xiaojiao, Jin Dan, Yi Yongdong, Bai Binglong, Li Hongzheng, Liang Danna, Lu Jianhua, Meng Letian, Wang Xiang, Cui Yuekai, Gu Yuyang, Shen Xian, Lu Xufeng, Rao Shangrui, Sun Weijian

СтатьяПеревод пока не подготовлен

Аннотация

Human gastric cancer (GC) is one of the most malignant cancers, and cisplatin (Cis)-based chemotherapy remains the main clinical treatment for GC. However, Cis resistance often occurs, largely limiting its therapeutic efficacy in tumors. Therefore, a better understanding of the drug resistance mechanism could reveal new approaches for improving GC treatment efficacy. Here, we define the integrative role of nucleolar and coiled-body phosphoprotein 1 (NOLC1), a molecular chaperone that is significantly upregulated in GC tissues and Cis-resistant GC cells. Knocking down NOLC1 increased GC sensitivity to Cis by regulating ferroptosis. Mechanistically, NOLC1 binds to the p53 DNA-binding domain (DBD), decreasing p53 nuclear accumulation stimulated by Cis and suppressing p53 transcriptional functions. Then, the p53-mediated ferroptosis is suppressed. Furthermore, the silence of NOLC1 promoted ferroptosis-induced immunogenic cell death (ICD) and reprogrammed the immunosuppressive tumor microenvironment, thereby increasing sensitivity to anti-programmed cell death-1 (PD-1) therapy plus Cis. The combination of anti-PD-1 plus Cis effectively inhibited GC growth without significant side effects. In summary, our findings reveal that targeting NOLC1 may be a novel therapeutic strategy for GC and may increase the efficacy of chemotherapy combined with immune checkpoint inhibitor (ICI) therapy.

Для цитирования: Zhao Shengsheng, Lin Ji, Zhu Bingzi, Jin Yin, Dong Qiantong, Ruan Xiaojiao, Jin Dan, Yi Yongdong, Bai Binglong, Li Hongzheng, Liang Danna, Lu Jianhua, Meng Letian, Wang Xiang, Cui Yuekai, Gu Yuyang, Shen Xian, Lu Xufeng, Rao Shangrui, Sun Weijian. NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer.. eLife. 2025. DOI: 10.7554/elife.103904.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.